Wacker Biotech

IN THE PRESS

BioMidwest

Caeregen Therapeutics and Wacker Biotech Announce Collaboration Agreement to Produce the Regenerative Medicine Clinical Candidate CTR-107 (Noregen™) for Retinal Diseases

June 28, 2023

·

6 min read

FDA

WACKER Obtains FDA Approval to Manufacture the Drug Substance in Retavase, a Thrombolysis Medication by Chiesi

January 9, 2018

·

2 min read

4950 S State Rd, Ann Arbor, Michigan - US

JOBS